| Active pulmonary tuberculosis |
| Extrapulmonary tuberculosis |
| Latent TB (preventive therapy, in combination regimens) |
Tablet
This fixed-dose combination is a cornerstone of first-line anti-tuberculosis therapy. Rifampicin and Isoniazid together provide potent bactericidal activity, preventing resistance and improving treatment outcomes.
| Speciality | Infectious Diseases | Pulmonology | Internal Medicine |
|---|---|
| Tags | Anti-TB | Combination Therapy | Rifampicin | Isoniazid | Tuberculosis |
| Strength |
|
| Packing Size |
|
All product details on this website are for reference and informational purposes only and
are not directed at patients or consumers.
As a contract manufacturer,
DM Pharma Pvt Ltd is not responsible for the marketing or end use of these products and disclaims all
liability arising from reliance on this information.
Please consult a healthcare professional before
using any medicinal product.